(Q37959106)

25 August 2017

Molecular pathology of gastric carcinoma (English)

1 reference

25 August 2017

0 references

Bo-Gun Jang

1

1 reference

PubMed ID

22104201

25 August 2017

Woo Ho Kim

series ordinal

2

1 reference

25 August 2017

18 November 2011

1 reference

25 August 2017

1 reference

25 August 2017

78

1 reference

25 August 2017

6

1 reference

25 August 2017

302-310

1 reference

Global cancer statistics, 2002

25 August 2017

1 reference

21 January 2018

Cancer statistics, 2006

1 reference

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

21 January 2018

1 reference

Helicobacter pyloriInfection

21 January 2018

1 reference

Pathology and molecular biology of gastric cancer

21 January 2018

1 reference

DNA methylation profiles of differentiated-type gastric carcinomas with distinct mucin phenotypes

21 January 2018

1 reference

Cell adhesion and signalling by cadherins and Ig-CAMs in cancer

21 January 2018

1 reference

Nature meets nurture: molecular genetics of gastric cancer.

21 January 2018

1 reference

Hereditary diffuse gastric cancer: diagnosis and management

21 January 2018

1 reference

Hereditary diffuse gastric cancer: a manifestation of lost cell polarity

21 January 2018

1 reference

E-cadherin deficiency initiates gastric signet-ring cell carcinoma in mice and man.

21 January 2018

1 reference

Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway

21 January 2018

1 reference

SHP-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori CagA protein

21 January 2018

1 reference

Helicobacter pylori vacuolating cytotoxin induces activation of the proapoptotic proteins Bax and Bak, leading to cytochrome c release and cell death, independent of vacuolation

21 January 2018

1 reference

IL-1B -31T>C promoter polymorphism is associated with gastric stump cancer but not with early onset or conventional gastric cancers.

21 January 2018

1 reference

Epstein-barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with epstein-barr virus-negative carcinoma

21 January 2018

1 reference

Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma

21 January 2018

1 reference

Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma

21 January 2018

1 reference

Survival advantage of EBV-associated gastric carcinoma: survivin up-regulation by viral latent membrane protein 2A.

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase

21 January 2018

1 reference

Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway

21 January 2018

1 reference

p53 mutations in human cancers

21 January 2018

1 reference

TP53 and gastric carcinoma: a review

21 January 2018

1 reference

p53 abnormalities in adenocarcinoma of the gastric cardia and antrum

21 January 2018

1 reference

Heterogeneity of p53 mutational status in the superficial spreading type of early gastric carcinoma.

21 January 2018

1 reference

Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway

21 January 2018

1 reference

Causal relationship between the loss of RUNX3 expression and gastric cancer

21 January 2018

1 reference

Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma

21 January 2018

1 reference

RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD.

21 January 2018

1 reference

The RUNX3 tumor suppressor upregulates Bim in gastric epithelial cells undergoing transforming growth factor beta-induced apoptosis

21 January 2018

1 reference

Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers

21 January 2018

1 reference

RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer

21 January 2018

1 reference

CDX2, a homeobox transcription factor, upregulates transcription of the p21/WAF1/CIP1 gene

21 January 2018

1 reference

Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach.

21 January 2018

1 reference

Cdx2 ectopic expression induces gastric intestinal metaplasia in transgenic mice.

21 January 2018

1 reference

CDX-2 homeobox gene expression in human gastric carcinoma and precursor lesions.

21 January 2018

1 reference

CDX2 expression is progressively decreased in human gastric intestinal metaplasia, dysplasia and cancer

21 January 2018

1 reference

CDX2 expression in the intestinal-type gastric epithelial neoplasia: frequency and significance.

21 January 2018

1 reference

Tumor microsatellite instability in early onset gastric cancer

21 January 2018

1 reference

Origin of microsatellite instability in gastric cancer

21 January 2018

1 reference

Distinct clinical features and outcomes of gastric cancers with microsatellite instability

21 January 2018

1 reference

Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival

21 January 2018

1 reference

Microsatellite instability in synchronous gastric carcinomas.

21 January 2018

1 reference

Gastrointestinal cancer of the microsatellite mutator phenotype pathway

21 January 2018

1 reference

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

21 January 2018

1 reference

HER-2 amplification is highly homogenous in gastric cancer.

21 January 2018

1 reference

Evaluation of HER-2 gene status in gastric carcinoma using immunohistochemistry, fluorescence in situ hybridization, and real-time quantitative polymerase chain reaction

21 January 2018

1 reference

HER-2/neu amplification is an independent prognostic factor in gastric cancer.

21 January 2018

1 reference

Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab.

21 January 2018

1 reference

Synergistic antitumor effect of S-1 and HER2-targeting agents in gastric cancer with HER2 amplification

21 January 2018

1 reference

The effectiveness of trastuzumab (Herceptin) combined with chemotherapy for gastric carcinoma with overexpression of the c-erbB-2 protein

21 January 2018

1 reference

[Her2 testing in gastric cancer. What is different in comparison to breast cancer?].

21 January 2018

1 reference

Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo.

21 January 2018

1 reference

Aberrant methylation and histone deacetylation associated with silencing of SLC5A8 in gastric cancer

21 January 2018

1 reference

DNA hypermethylation in gastric cancer

21 January 2018

1 reference

Promoter hypermethylation of tumor-related genes in gastric intestinal metaplasia of patients with and without gastric cancer.

21 January 2018

1 reference

Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma

21 January 2018

1 reference

Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2'-deoxycytidine treatment and oligonucleotide microarray

21 January 2018

1 reference

Aberrant DNA methylation is a dominant mechanism in MDS progression to AML.

21 January 2018

1 reference

The epigenetic progenitor origin of human cancer

21 January 2018

1 reference

Novel targeted therapies in the treatment of gastric and esophageal cancer

21 January 2018

1 reference

Early Gastric Cancer in Young, Asymptomatic Carriers of Germ-Line E-Cadherin Mutations

21 January 2018

1 reference

E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma

21 January 2018

1 reference

A proinflammatory genetic profile increases the risk for chronic atrophic gastritis and gastric carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000321703

1 reference

25 August 2017

1 reference

PubMed ID

22104201